|
|
Product List Page 3506
|
|
Product ID |
Product Name |
CAS# |
Purity |
Y3290819 |
Vilazodone D8 |
1794789-93-7 |
98% |
Y3307366 |
SPD-473 citrate |
161190-26-7 |
99% |
Y3308067 |
Nitroxazepine |
47439-36-1 |
98% |
Y1333658 |
Parsaclisib |
1426698-88-5 |
99% |
Y3317184 |
Setmelanotide |
920014-72-8 |
98% |
Y3104959 |
Olcegepant hydrochloride |
586368-06-1 |
99% |
Y3311418 |
Neurokinin antagonist 1 |
214487-45-3 |
100% |
Y1249395 |
MAO-IN-1 |
124991-40-8 |
99% |
Y3191992 |
3,18-diethenyl-1,19,22,24-tetrahydro-2,7,13,17-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoicacid,monohydrochloride |
856699-18-8 |
95% |
Y3307921 |
2-[(1-methylethyl)amino]-1-phenyl-1-pentanone,monohydrochloride |
18268-14-9 |
99.98% |
Y1253929 |
N-(4,6-dimethyl-2-pyridinyl)-4-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinecarbothioamide |
1542213-00-2 |
99% |
Y3289048 |
4-[5-(4-fluorophenyl)-2-(methylthio)-1H-imidazol-4-yl]-N-[(1S)-1-phenylethyl]-2-pyridinamine |
581098-48-8 |
98% |
Y3296959 |
N-[2-[(1R,2R)-3-oxo-2-(2Z)-2-penten-1-ylcyclopentyl]acetyl]-L-isoleucine,N-[2-[(1S,2S)-3-oxo-2-(2Z)-2-penten-1-ylcyclopentyl]acetyl]-L-isoleucine |
120330-93-0 |
98% |
Y1258123 |
4'-[1-[[2-(phenylmethyl)-1-piperidinyl]carbonyl]-1H-1,2,3-triazol-4-yl]-[1,1'-biphenyl]-3-carboxylicacid |
1402612-64-9 |
99% |
Y3255347 |
[4-[3'-(hydroxymethyl)[1,1'-biphenyl]-4-yl]-1H-1,2,3-triazol-1-yl](2-phenyl-1-piperidinyl)-methanone |
1402612-62-7 |
99% |
Y3253883 |
6-quinolinyl(3,4,5-trimethoxyphenyl)methanone |
1215208-59-5 |
99% |
Y3288177 |
4-(4-methoxyphenyl)-1-piperazinecarboxylicacid,hexahydro-1,3-dioxo-7-[(4-phenoxyphenyl)methyl]imidazo[1,5-a]pyrazin-2-ylester |
1831135-56-8 |
99% |
Y1344596 |
N-ethyl-1-(3-methoxyphenyl)-cyclohexanamine,monohydrochloride |
1797121-52-8 |
95% |
Y1249542 |
N-[(3a,5ß,7a,12a)-3,7,12-trihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]-glycine |
1201918-15-1 |
98%D |
Y1253816 |
5Z,8Z,11Z,14Z,17Z-eicosapentaenoicacid,monosodiumsalt |
73167-03-0 |
99% |
Y3183092 |
9Z,12Z,15Z-octadecatrienoicacid,monosodiumsalt |
822-18-4 |
98% |
Y1329511 |
2-furanyl[4-(5,6,7,8-tetrahydro-2-methyl[1]benzothieno[2,3-d]pyrimidin-4-yl)-1-piperazinyl]-methanone |
460331-61-7 |
95% |
Y3201569 |
2-hydroxy-benzoicacid,2-[1-(2-hydroxyphenyl)ethylidene]hydrazide |
15533-09-2 |
97% |
Y3288836 |
2-[[(3a,5ß,7a,12a)-3,7,12-trihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]amino]-ethanesulfonicacid,monosodiumsalt |
2410279-93-3 |
99% |
Y1258160 |
1-[[3-bromo-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-piperidinecarboxylicacid |
1675201-90-7 |
95% |
Y3293470 |
2,3,4,5,6-pentafluoro-N-[4-hydroxy-3-(phenylthio)-1-naphthalenyl]-benzenesulfonamide |
1809581-87-0 |
95% |
Y1249544 |
N-[3-oxo-3-[[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]propyl]-4-(trifluoromethoxy)-benzamide |
2029049-79-2 |
98% |
Y3102541 |
8-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-2-naphthalenol,monohydrochloride |
76275-67-7 |
95% |
Y1258124 |
6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole-4,5,7-d3 |
934293-92-2 |
98%D |
Y3183058 |
4Z,7Z,10Z,13Z,16Z-docosapentaenoicacid,ethylester |
142828-42-0 |
95% |
Y3190390 |
S-(hydrogen2-ethylpropanedioate)coenzymeA |
6049-57-6 |
98% |
Y1262571 |
(2E)-N-[(5-bromo-2-methoxyphenyl)sulfonyl]-3-[5-chloro-2-(2-naphthalenylmethyl)phenyl]-2-propenamide |
244101-03-9 |
98% |
Y1253750 |
N-[4-[[3-(acetylamino)propyl]amino]butyl]-acetamide,monohydrochloride |
178244-42-3 |
98% |
Y3293739 |
3-((3R,4R)-4-methyl-3-((methyl-d3)(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile2-hydroxypropane-1,2,3-tricarboxylate |
2701680-77-3 |
99% |
Y1258214 |
20R-[(4R)-4-methyl-5-hexyn-1-yl]-pregn-5-en-3ß-ol |
1527467-07-7 |
95% (NMR) |
Y3107699 |
(2-(3-(5,5-difluoro-7-((1E,3E)-4-phenylbuta-1,3-dien-1-yl)-5H-54,64-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-3-yl)propanamido)ethyl)triphenylphosphonium,monobromide |
1392820-50-6 |
95% |
Y3310590 |
3S-(1-methylethyl)-6S-(phenylmethyl)-2,5-piperazinedione |
35590-86-4 |
99.88% |
Y3306252 |
(1S)-1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl-2,3,5,6-d4)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol |
1997338-61-0 |
98% |
Y3288674 |
(3aS)-1,2,3,3a-tetrahydro-3a-hydroxy-6-methyl-1-(4-nitrophenyl)-4H-pyrrolo[2,3-b]quinolin-4-one |
1621326-32-6 |
99% |
Y3186416 |
1,2,3,4,6-pentakis[3,4-dihydroxy-5-[(3,4,5-trihydroxybenzoyl)oxy]benzoate]ß-D-glucopyranose |
5424-20-4 |
96% |
Y3311645 |
N-[4-[(3,4-dihydro-3-oxopyrido[2,3-b]pyrazin-8-yl)oxy]-2-(methylthio)phenyl]-N'-[3-(1,1-dimethylethyl)-1-phenyl-1H-pyrazol-5-yl]-urea |
1163719-91-2 |
98% |
Y3297286 |
4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-9-(2-((2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)amino)acetamido)-1,11-dioxo-1,4S,4aS,5,5aR,6,11,12aS-octahydrotetracene-2-carboxamide |
2699607-86-6 |
97% |
Y3295790 |
(OC-6-33)-tricarbonyl(1,10-phenanthroline-N1,N10)[4-(2H-tetrazol-5-yl-N2)pyridinato]-rhenium |
1404104-40-0 |
99% |
Y3107703 |
(2S)-2-[[(4-methylphenyl)sulfonyl]amino]-9,13-dioxo-14-phenyl-7-[[[[(2-phenylacetyl)oxy]methoxy]carbonyl]amino]-10,12-dioxa-6,8-diazatetradec-6-enoicacid,methylester |
1362911-19-0 |
98% |
Y1262572 |
5-[3,4-difluoro-2-[2-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethoxy]phenyl]-N,N,1-trimethyl-1H-indazole-3-methanamine |
2059148-82-0 |
98% |
Y3306254 |
1-[(4-chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]-piperazine-2,2,3,3,5,5,6,6-d8,dihydrochloride |
1432062-16-2 |
98% |
Y3305713 |
7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl-2,2,3,3,5,5,6,6-d8)butoxy]-2(1H)-quinolinone |
1427049-21-5 |
99% |
Y3107684 |
N-[-6,6-dimethyl-2-hepten-4-yn-1-yl]-N-(methyl-d3)-1-naphthalenemethanamine,monohydrochloride |
1310012-15-7 |
99% |
Y3190488 |
1-acetyl-L-prolyl-L-alanyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-leucinamide |
1431362-79-6 |
98% |
Y3309979 |
JNJ37822681dihydrochloride |
935776-74-2 |
99% |
Y3292132 |
DG2-S6K1InhibitorDG2 |
871340-88-4 |
99% |
Y3102645 |
LIMK1inhibitorBMS4-BMS4 |
905298-84-2 |
99.0% |
Y3293177 |
ONO5334 |
868273-90-9 |
99% |
Y3307677 |
Brexpiprazoledihydrochloride-OPC34712dihydrochloride |
913612-38-1 |
95% |
Y3190379 |
AZ13705339 |
2016806-57-6 |
98%(HPLC) |
Y3292594 |
YUKA1 |
708991-09-7 |
99% |
Y3290735 |
TD52 |
1798328-24-1 |
99% |
Y3102527 |
Rbin-2-Ribozinoindole-2 |
2032282-97-4 |
98% |
Y3188725 |
ThioLox-ThiopheneA9 |
1202193-89-2 |
98% |
Y3310069 |
Benzamide Derivative 1 |
108226-05-7 |
100% |
Y1245122 |
Nuvenzepine |
96487-37-5 |
99% |
Y3104962 |
YM-58790 |
214558-72-2 |
98% |
Y3304712 |
UK-240455 |
178908-09-3 |
98% |
Y3310894 |
FG8119 |
106447-61-4 |
100% |
Y1253839 |
AZD-6280 |
942436-93-3 |
98% |
Y3309459 |
5-HT6/7 antagonist 1 |
131999-28-5 |
98% |
Y3191778 |
ABT-670 |
630119-43-6 |
98% |
Y1249373 |
NMI 8739 |
129024-87-9 |
97% |
Y1253840 |
TPA 023 |
252977-51-8 |
95% |
Y3171322 |
Netupitant D6 |
2070015-31-3 |
95% |
Y1249396 |
Y1 receptor antagonist 1 |
221697-09-2 |
99% |
Y1343419 |
BACE1-IN-1 |
1310347-50-2 |
99% |
Y3305405 |
Xanthine oxidase-IN-1 |
1071970-13-2 |
98% |
Y3309638 |
MK-3328 |
1201323-97-8 |
98% |
Y1249375 |
Pyridostigmine D6 bromide |
2375858-08-3 |
98% |
Y3311492 |
5-HT2 antagonist 1 |
191592-09-3 |
99% |
Y1245123 |
Revexepride |
219984-49-3 |
95% |
Y1249517 |
5-HT1A modulator 1 |
142477-34-7 |
97% |
Y1249397 |
Tedatioxetine hydrobromide |
960151-65-9 |
99% |
Y3308509 |
Nexopamil racemate |
116759-35-4 |
98% |
Y1249376 |
SB-616234A |
908601-49-0 |
98% |
Y3311605 |
PRX933 hydrochloride |
639029-42-8 |
97% |
Y1249420 |
AGN 194078 |
321995-62-4 |
98% |
Y1249377 |
Trifarotene |
895542-09-3 |
97% |
Y1253766 |
Capzimin |
2084868-04-0 |
99% |
Y1253905 |
ABX-1431 |
1446817-84-0 |
98% |
Y1249519 |
RGX-104 |
610318-03-1 |
99% |
Y3294779 |
CDC801 |
192819-27-5 |
98% |
Y3307178 |
PDE IV-IN-1 |
225100-12-9 |
98% |
Y1253796 |
LMPTP INHIBITOR 1 dihydrochloride |
2310135-46-5 |
99% |
Y1339179 |
Rosiptor |
782487-28-9 |
98% |
Y1249378 |
PTP1B-IN-2 |
1919853-46-5 |
98% |
Y1253907 |
BAY 73-6691 racemate |
794568-90-4 |
99% |
Y3292791 |
1-Piperazinecarboxylic acid, 4-[3-(2,3-dihydro-2-oxo-6-benzoxazolyl)-3-oxopropyl]-, (3,5-dichlorophenyl)methyl ester, hydrochloride (1:1) |
2070015-01-7 |
98% |
Y1249440 |
CI-1044 |
197894-84-1 |
98% |
Y1253767 |
Mardepodect hydrochloride |
2070014-78-5 |
95% |
Y1245125 |
IACS-8968 |
2144425-14-7 |
98% |
Y1253908 |
IACS-8968 S-enantiomer |
2239305-70-3 |
98% |
Y1258221 |
IDO-IN-3 |
2070018-30-1 |
98% |
Y1249441 |
TLK117 |
152684-53-2 |
98% |
|
|
|
|
|
|